Ethanol-To-Butanol Conversion A Biofuel Plus
ACS Meeting News: Catalytic process creates butanol as a better biofuel option for gasoline
Ethanol-To-Butanol Conversion A Biofuel Plus Read More »
Green Valley Drugs: Recall of All Lots of All Sterile Products – Quality Control Concerns
Audience: Healthcare Professional, Consumer ISSUE: Green Valley Drugs notified healthcare professionals and their organizations about the recall of all lots of all sterile products compounded, repackaged, and distributed by the pharmacy due to lack…
Affirm XL Recall – Undeclared Drug Ingredient
Audience: Consumer ISSUE: Affirm XL, Inc. is conducting a voluntary recall to the consumer level after FDA lab analysis testing found the product to contain an analogue of sildenafil. Sildenafil is an active ingredient used in an FDA-approved…
Affirm XL Recall – Undeclared Drug Ingredient Read More »
Bristol-Myers Squibb Names New R&D Head
Pharmaceuticals: Firm is third to change R&D directors in recent months
Bristol-Myers Squibb Names New R&D Head Read More »
Reducing Environmental Impact Of Organic Synthesis
ACS Meeting News: Running common reactions in aqueous micelle solutions makes them significantly greener
Reducing Environmental Impact Of Organic Synthesis Read More »
Unexpected Uranium Chemistry Found In Contaminated Aquifer
ACS Meeting News: Results will aid remediation efforts
Unexpected Uranium Chemistry Found In Contaminated Aquifer Read More »
Bristol-Myers Squibb Names New R&D Head
Pharmaceuticals: Firm is third to change R&D directors in recent months
Bristol-Myers Squibb Names New R&D Head Read More »
Preventing Battery Explosions
ACS Meeting News: Novel electrolytes could solve flammability problems that grounded Boeing Dreamliners
Preventing Battery Explosions Read More »
Nanosolder For Safer Surgery
Nanomedicine: Composites of peptides and gold nanorods could help surgeons seal up incisions using laser light
Nanosolder For Safer Surgery Read More »
Gilead Submits New Drug Application to U.S. FDA for Sofosbuvir for the Treatment of Hepatitis C
FOSTER CITY, Calif.–April 8, 2013–BUSINESS WIRE–Gilead Sciences today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of sofosbuvir, a once-daily oral nucleotide…